Predicted to enable short-chain fatty acid transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Predicted to be involved in hormone transport; short-chain fatty acid transmembrane transport; and sodium-independent organic anion transport. Predicted to be located in basolateral plasma membrane. Human ortholog(s) of this gene implicated in Lynch syndrome and mismatch repair cancer syndrome. Orthologous to several human genes including SLC22A9 (solute carrier family 22 member 9).
RGD Description
Predicted to enable short-chain fatty acid transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Predicted to be involved in hormone transport; short-chain fatty acid transmembrane transport; and sodium-independent organic anion transport. Predicted to be located in basolateral plasma membrane. Human ortholog(s) of this gene implicated in Lynch syndrome and mismatch repair cancer syndrome. Orthologous to several human genes including SLC22A9 (solute carrier family 22 member 9); INTERACTS WITH 4-methylumbelliferone sulfate; ammonium chloride; bisphenol A.